PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 16, 2018The Journal of Infectious Diseases31 citationsOpen Access

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate

View Full Paper
JSJesica SwanstromSHSandra HeneinJPJessica A. Plante

Key Points

Key points are not available for this paper at this time.

Abstract

Here we provide qualitative measures of the magnitude and epitope specificity of the nAb responses to TDV. This information will be useful for understanding the performance of TDV in clinical trials and for identifying correlates of protective immunity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Swanstrom et al. (2018) studied this question.

synapsesocial.com/papers/69dabcac7a67537a8ba3c1f2https://doi.org/10.1093/infdis/jiy063
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity2010 · 605 citations
  2. 2Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease2015 · 1,098 citations
  3. 3Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 42017 · 25 citations
  4. 4Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV12016 · 35 citations
  5. 5Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study2015 · 69 citations